Literature DB >> 12135926

Spatially specific expression of Hoxb4 is dependent on the ubiquitous transcription factor NFY.

Jonathan Gilthorpe1, Marie Vandromme, Tim Brend, Alejandro Gutman, Dennis Summerbell, Nick Totty, Peter W J Rigby.   

Abstract

Understanding how boundaries and domains of Hox gene expression are determined is critical to elucidating the means by which the embryo is patterned along the anteroposterior axis. We have performed a detailed analysis of the mouse Hoxb4 intron enhancer to identify upstream transcriptional regulators. In the context of an heterologous promoter, this enhancer can establish the appropriate anterior boundary of mesodermal expression but is unable to maintain it, showing that a specific interaction with its own promoter is important for maintenance. Enhancer function depends on a motif that contains overlapping binding sites for the transcription factors NFY and YY1. Specific mutations that either abolish or reduce NFY binding show that it is crucial for enhancer activity. The NFY/YY1 motif is reiterated in the Hoxb4 promoter and is known to be required for its activity. As these two factors are able to mediate opposing transcriptional effects by reorganizing the local chromatin environment, the relative levels of NFY and YY1 binding could represent a mechanism for balancing activation and repression of Hoxb4 through the same site.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135926     DOI: 10.1242/dev.129.16.3887

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  17 in total

1.  The Arabidopsis locus RCB mediates upstream regulation of mitotic gene expression.

Authors:  Kristiina Himanen; Christophe Reuzeau; Tom Beeckman; Siegbert Melzer; Olivier Grandjean; Liz Corben; Dirk Inze
Journal:  Plant Physiol       Date:  2003-12       Impact factor: 8.340

2.  Musculin and TCF21 coordinate the maintenance of myogenic regulatory factor expression levels during mouse craniofacial development.

Authors:  Natalia Moncaut; Joe W Cross; Christine Siligan; Annette Keith; Kevin Taylor; Peter W J Rigby; Jaime J Carvajal
Journal:  Development       Date:  2012-03       Impact factor: 6.868

3.  The histone-like NF-Y is a bifunctional transcription factor.

Authors:  Michele Ceribelli; Diletta Dolfini; Daniele Merico; Raffaella Gatta; Alessandra M Viganò; Giulio Pavesi; Roberto Mantovani
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

4.  Nuclear transcription factor Y and its roles in cellular processes related to human disease.

Authors:  Luong Linh Ly; Hideki Yoshida; Masamitsu Yamaguchi
Journal:  Am J Cancer Res       Date:  2013-08-14       Impact factor: 6.166

Review 5.  The role of Hox proteins in leukemogenesis: insights into key regulatory events in hematopoiesis.

Authors:  Elizabeth Eklund
Journal:  Crit Rev Oncog       Date:  2011

6.  Nuclear factor Y and steroidogenic factor 1 physically and functionally interact to contribute to cell-specific expression of the mouse Follicle-stimulating hormone-beta gene.

Authors:  Suzanne B R Jacobs; Djurdjica Coss; Shauna M McGillivray; Pamela L Mellon
Journal:  Mol Endocrinol       Date:  2003-05-01

7.  A novel AP-1 site is critical for maximal induction of the follicle-stimulating hormone beta gene by gonadotropin-releasing hormone.

Authors:  Djurdjica Coss; Suzanne B R Jacobs; Cheryl E Bender; Pamela L Mellon
Journal:  J Biol Chem       Date:  2003-10-20       Impact factor: 5.157

Review 8.  The Yin and Yang of YY1 in the nervous system.

Authors:  Ye He; Patrizia Casaccia-Bonnefil
Journal:  J Neurochem       Date:  2008-05-15       Impact factor: 5.372

9.  Molecular integration of wingless, decapentaplegic, and autoregulatory inputs into Distalless during Drosophila leg development.

Authors:  Carlos Estella; Daniel J McKay; Richard S Mann
Journal:  Dev Cell       Date:  2008-01       Impact factor: 12.270

10.  Identification of a novel erythroid-specific enhancer for the ALAS2 gene and its loss-of-function mutation which is associated with congenital sideroblastic anemia.

Authors:  Kiriko Kaneko; Kazumichi Furuyama; Tohru Fujiwara; Ryoji Kobayashi; Hiroyuki Ishida; Hideo Harigae; Shigeki Shibahara
Journal:  Haematologica       Date:  2013-08-09       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.